Nivolumab and Ipilimumab With or Without Local Consolidation Therapy in Treating Patients With Stage IV Non-Small Cell Lung Cancer

NCT03391869 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

339

Enrollment

OTHER

Sponsor class

Conditions

Lung Adenocarcinoma
Lung Non-Small Cell Carcinoma
Stage IV Lung Cancer AJCC v8

Interventions

BIOLOGICAL: Ipilimumab
PROCEDURE: Local Consolidation Therapy
BIOLOGICAL: Nivolumab
OTHER: Quality-of-Life Assessment
RADIATION: Radiation Therapy
PROCEDURE: Therapeutic Conventional Surgery

Sponsor

M.D. Anderson Cancer Center